SEC Form 4 · accession 0001387131-15-000431
Ohr Pharmaceutical Inc · OHRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Irach B. Taraporewala
Officer — Chief Executive Officer · Director
Period of report
Feb 6, 2015
Accepted (ET)
Feb 10, 2015 · 12:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001173281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Feb 6, 2015 | P | 3,705 | $6.75 | A | 22,800 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF1 | $1.50 | holding | — | — | — | Apr 12, 2010 | Apr 12, 2015 | Common Stock | 266,667 | 266,667 | D |
| OptionF2 | $1.71 | holding | — | — | — | Mar 9, 2014 | Mar 9, 2017 | Common Stock | 233,333 | 233,333 | D |
| OptionF3 | $10.11 | holding | — | — | — | Feb 3, 2014 | Feb 3, 2017 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1All exercisable.
- F258,333 options are currently unexercisable until March 9, 2015.
- F3125,000 options are currently unexercisable; half will become exercisable February 3, 2015 and half will become exercisable February 3, 2016.